SunTrust Starts Mobileye N.V (MBLY) at Buy
- Wall Street rallies as OPEC reaches output deal
- Pier 1 Imports (PIR) Reports In-Line Q2 EPS; Comps Fall 4.3%
- Intra-Cellular Therapies (ITCI) Announces ITI-007 Phase 3 Missed Primary Endpoint in Schizophrenia
- Vertex Pharma (VRTX) Announces FDA Approval for ORKAMBI in Children 6-11; Lowers 2016 ORKAMBI Revenue Outlook
- After-Hours Stock Movers 09/28: (AEGR) (PIR) (GSAT) Higher; (ITCI) (ATNM) (PRGS) Lower (more...)
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
SunTrust Robinson Humphrey initiated coverage on Mobileye N.V (NYSE: MBLY) with a Buy rating and a price target of $63.00.
Shares of Mobileye N.V closed at $42.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Janney Montgomery Scott Starts Intellia Therapeutics (NTLA) at Buy
- Janney Montgomery Scott Starts Ionis Pharmaceuticals (IONS) at Buy
- Janney Montgomery Scott Starts ProQR Therapeutics N.V. (PRQR) at Neutral
Create E-mail Alert Related CategoriesHot New Coverage, New Coverage
Related EntitiesSunTrust Robinson Humphrey
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!